Ablation versus medication as initial therapy for paroxysmal atrial fibrillation: An updated meta‐analysis of randomized controlled trials

BACKGROUND: Recent randomized controlled trials (RCTs) suggest that ablation is superior to antiarrhythmic drugs (AADs) as an initial therapy for paroxysmal atrial fibrillation (pAF) to prevent arrhythmia recurrences. We performed an updated meta‐analysis of RCTs, to include recent data from cryobal...

Descripción completa

Detalles Bibliográficos
Autores principales: Kewcharoen, Jakrin, Prasitlumkum, Narut, Chokesuwattanaskul, Ronpichai, Yi, Ruiyang, Jongnarangsin, Krit, Bunch, Thomas J., Ranjan, Ravi, Navaravong, Leenhapong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637078/
https://www.ncbi.nlm.nih.gov/pubmed/34887949
http://dx.doi.org/10.1002/joa3.12641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637078/
https://www.ncbi.nlm.nih.gov/pubmed/34887949
http://dx.doi.org/10.1002/joa3.12641

Ejemplares similares